Sanofi to acquire Principia Biopharma
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sanofi
Sanofi, GSK to supply 100 mn doses of COVID-19 vaccine to US, in talks with EU for 300 mn doses
The deal is worth $2.1 billion and involves the supply of vaccines for 50 million people, with the option to buy another 500…
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year,…
Regeneron, Sanofi arthritis drug fails COVID-19 study
Previous trial results had shown that the drug did not help patients with less severe COVID-19, the disease caused by the novel…
Sanofi clinches $2-bn vaccines deal with Translate Bio
The deal strengthens Sanofi’s credentials in a market engaged in a frantic race to find a safe and effective vaccine against the…
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be…
Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection
FDA approval marks a significant milestone to help increase access and affordability of insulin for the millions of Americans…
Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for…
Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
Sanofi says its COVID-19 vaccine will available in all countries
The statement comes after the French government took objection to Sanofi CEO’s earlier comment that the US will get first access…